Jan 30 (Reuters) - ARAB DRUG COMPANY FOR PHARMACEUTICALS AND CHEMICAL INDUSTRIES:
* H1 NET PROFIT AFTER TAX EGP 18.4 MILLION VERSUS EGP 10.2 MILLION YEAR AGO Source: ( bit.ly/2nokpjS ) Further company coverage:
 